By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
News

Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose

Jimmie Dempsey
Last updated: June 15, 2025 8:02 pm
Jimmie Dempsey Published June 15, 2025
Share
SHARE

NEWYou can now listen to Fox News articles!

A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk.

The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia.

The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release. 

THIS CHEAP PANTRY STAPLE COULD BE KEY TO LOWERING CHOLESTEROL, NEW RESEARCH SUGGESTS

All participants were receiving “maximum tolerated doses” of cholesterol-lowering therapy.

One group received Obicetrapib and another group took a placebo, while still maintaining their existing cholesterol drugs. 

After 12 weeks, the participants taking the new drug showed a 32.6% reduction in LDL cholesterol and a 33.5% drop in lipoprotein(a) [Lp(a)], the release stated.

The findings were presented last month at the European Atherosclerosis Society Congress in the U.K. and were also published in The New England Journal of Medicine.

WOMEN’S HEART DISEASE RISK COULD BE PREDICTED UP TO 30 YEARS IN ADVANCE WITH ONE BLOOD TEST, STUDY FINDS

“We know that many people at high risk of heart attack or stroke don’t get their cholesterol levels low enough, even on the best available treatments,” said study lead Professor Stephen Nicholls, director of Monash University’s Victorian Heart Institute and Monash Health’s Victorian Heart Hospital, in the release.

“We know that many people at high risk of heart attack or stroke don’t get their cholesterol levels low enough, even on the best available treatments.”

“Obicetrapib offers a promising new option — not only did it lower LDL cholesterol by over 30%, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk.”

LDL cholesterol

Low-density lipoprotein (LDL), which is sometimes called “bad cholesterol,” is associated with negative health effects when present in high amounts.

LDL can build up in the blood vessels and increase heart attack and stroke risk, the researchers cautioned.

Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase the chances of a heart attack when it’s present in high levels in the blood.

Unlike LDL, Lp(a) is an inherited risk factor that can’t be modified with healthy behaviors or medications.

Man holding chest

Obicetrapib was found to be “well-tolerated” by the participants, the researchers noted. 

“This could be a valuable tool in the fight against heart disease,” Nicholls added. “It’s convenient, it’s effective, and it may help close the gap for patients who’ve run out of options.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study — which was funded by NewAmsterdam Pharma, a developer of Obicetrapib that is based in the Netherlands — did have some limitations, the researchers noted.

man puts pill in mouth

For example, the participants were not chosen based on high Lp(a), which means the study did not determine how the drug impacted those with elevated levels of the protein.

Additionally, the study assessed changes in LDL levels, but did not measure actual heart attack or stroke outcomes.

For more Health articles, visit www.foxnews.com/health

More studies are needed to follow patients for longer time periods and to include more diverse cohorts, the researchers acknowledged.

Fox News Digital reached out to the researchers for additional comment.

Read the full article here

You Might Also Like

Senate DOGE Republican pushes bill to bring government computer systems ‘out of the stone age’

BYU football player Jake Retzlaff accused of 2023 sexual assault in lawsuit

Wyndham Clark admits he ‘made a mistake,’ expresses regret over US Open locker room tirade

Trump admin reinstates 9/11 survivors program staff following HHS reorganization

Terrifying video gives inside look at what it would be like to be eaten by a shark

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
‘Three’s Company’ actress Jenilee Harrison refused to strip down for her Playboy photoshoot
News

‘Three’s Company’ actress Jenilee Harrison refused to strip down for her Playboy photoshoot

Jimmie Dempsey Jimmie Dempsey July 6, 2025
First Look: New Knives from SIG Sauer And Eikonic
Father’s pursuit for missing daughter heats up with new evidence in case that’s no longer cold
Sunday Shoot-a-Round # 288
Utah building explodes into the sky after vehicle crashes into business, causes fire
Candace Cameron Bure warns about ‘scary’ Hollywood weight-loss trend making a comeback
American with ‘CIA’ credentials and variety of weapons arrested in Mexico
News

American with ‘CIA’ credentials and variety of weapons arrested in Mexico

Jimmie Dempsey Jimmie Dempsey July 6, 2025
Texas police officer shot near ICE detention center as Trump officials promise zero tolerance
News

Texas police officer shot near ICE detention center as Trump officials promise zero tolerance

Jimmie Dempsey Jimmie Dempsey July 6, 2025
FBI Deputy Director Dan Bongino slams New York Times for ‘poorly thought-out hit piece’
News

FBI Deputy Director Dan Bongino slams New York Times for ‘poorly thought-out hit piece’

Jimmie Dempsey Jimmie Dempsey July 6, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?